Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
311.35
-2.6 (-0.83%)
BSENSE

Dec 05

BSE+NSE Vol: 49.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
22.38
22.36
22.36
22.36
22.35
22.34
Share Warrants & Outstandings
Total Reserve
1,393.53
1,298.73
1,212.70
1,065.59
945.97
813.71
Shareholder's Funds
1,420.86
1,324.13
1,235.07
1,088.59
970.94
839.65
Minority Interest
47.81
46.95
49.10
51.79
61.68
27.80
Long-Term Borrowings
9.18
6.96
7.80
8.13
9.87
4.15
Secured Loans
9.18
6.96
7.80
8.13
9.70
3.44
Unsecured Loans
0.00
0.00
0.00
0.00
0.17
0.71
Deferred Tax Assets / Liabilities
23.44
20.04
25.89
31.83
33.98
25.43
Other Long Term Liabilities
11.73
15.86
14.58
18.35
3.92
13.3
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.37
0.89
0.51
1.07
1.36
1.30
Total Non-Current Liabilities
45.73
43.74
48.77
59.38
49.13
38.71
Current Liabilities
Trade Payables
17.20
15.76
24.22
17.90
15.22
9.64
Other Current Liabilities
45.83
52.77
44.19
35.89
39.10
33.94
Short Term Borrowings
12.35
18.15
5.44
2.81
9.19
12.74
Short Term Provisions
21.37
19.68
3.72
3.82
4.04
3.23
Total Current Liabilities
96.75
106.36
77.57
60.42
67.56
59.55
Total Liabilities
1,611.15
1,521.18
1,410.51
1,260.19
1,149.31
971.18
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
965.78
902.23
867.77
805.88
467.53
0.00
Less: Accumulated Depreciation
287.11
252.49
218.71
186.77
152.07
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
678.67
649.75
649.06
619.11
315.46
268.74
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
21.69
30.74
15.61
9.63
4.86
4.76
Intangible assets under development
0.02
10.36
5.89
5.44
5.38
5.38
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.07
0.17
0.17
0.07
0.07
0.06
Long Term Loans & Advances
23.85
19.00
16.34
17.50
14.88
16.68
Other Non Current Assets
340.43
326.72
322.19
300.07
292.64
299.99
Total Non-Current Assets
731.29
711.44
688.40
655.75
633.29
595.61
Current Assets Loans & Advances
Current Investments
480.26
402.85
359.55
101.95
121.31
123.53
Inventories
157.31
148.46
123.99
120.92
93.88
80.03
Sundry Debtors
115.40
98.57
100.34
88.21
86.27
74.69
Cash and Bank
107.69
126.95
123.35
273.63
197.77
83.02
Other Current Assets
5.30
6.59
5.08
9.16
5.52
6.25
Short Term Loans and Advances
13.93
26.33
9.80
10.58
11.25
8.05
Total Current Assets
879.87
809.74
722.11
604.44
516.01
375.57
Net Current Assets (Including Current Investments)
783.11
703.38
644.54
544.02
448.46
316.03
Total Current Assets Excluding Current Investments
399.61
406.89
362.56
502.49
394.70
252.05
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,611.15
1,521.18
1,410.51
1,260.19
1,149.31
971.18
Contingent Liabilities
9.31
5.36
5.43
5.41
11.28
13.55
Total Debt
21.54
25.11
13.24
10.94
19.07
17.67
Book Value per share (adjusted)
127
118.41
110.45
97.37
86.9
75.18
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -14.22% vs 89.65% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -26.04% vs 8.78% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 2.92% vs 2.38% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -58.82% vs 0.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 8.66% vs 12.14% in Mar 2024

Compare Balance Sheet Results of Advanced Enzyme
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
22.38
10.13
12.25
120.93%
Share Warrants & Outstandings
Total Reserve
1,393.53
590.94
802.59
135.82%
Shareholder's Funds
1,420.86
601.08
819.78
136.38%
Minority Interest
47.81
0.00
47.81
0.00%
Long-Term Borrowings
9.18
130.50
-121.32
-92.97%
Secured Loans
9.18
130.50
-121.32
-92.97%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
23.44
7.77
15.67
201.67%
Other Long Term Liabilities
11.73
24.97
-13.24
-53.02%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.37
17.49
-16.12
-92.17%
Total Non-Current Liabilities
45.73
180.73
-135.00
-74.70%
Current Liabilities
Trade Payables
17.20
158.75
-141.55
-89.17%
Other Current Liabilities
45.83
44.53
1.30
2.92%
Short Term Borrowings
12.35
179.88
-167.53
-93.13%
Short Term Provisions
21.37
4.40
16.97
385.68%
Total Current Liabilities
96.75
387.56
-290.81
-75.04%
Total Liabilities
1,611.15
1,169.36
441.79
37.78%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
965.78
558.16
407.62
73.03%
Less: Accumulated Depreciation
287.11
76.64
210.47
274.62%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
678.67
481.52
197.15
40.94%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
21.69
21.82
-0.13
-0.60%
Intangible assets under development
0.02
0.00
0.02
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.07
1.78
-1.71
-96.07%
Long Term Loans & Advances
23.85
13.18
10.67
80.96%
Other Non Current Assets
340.43
2.06
338.37
16,425.73%
Total Non-Current Assets
731.29
544.84
186.45
34.22%
Current Assets Loans & Advances
Current Investments
480.26
0.00
480.26
0.00%
Inventories
157.31
216.87
-59.56
-27.46%
Sundry Debtors
115.40
314.61
-199.21
-63.32%
Cash and Bank
107.69
29.02
78.67
271.09%
Other Current Assets
5.30
3.07
2.23
72.64%
Short Term Loans and Advances
13.93
60.95
-47.02
-77.15%
Total Current Assets
879.87
624.52
255.35
40.89%
Net Current Assets (Including Current Investments)
783.11
236.97
546.14
230.47%
Total Current Assets Excluding Current Investments
399.61
624.52
-224.91
-36.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,611.15
1,169.36
441.79
37.78%
Contingent Liabilities
9.31
5.86
3.45
58.87%
Total Debt
21.54
310.37
-288.83
-93.06%
Book Value per share (adjusted)
127.00
59.93
67.07
111.91%
Annual - Borrowings
Borrowings 21.54 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.22% vs 89.65% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 11.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -26.04% vs 8.78% in Mar 2024

Annual - Fixed Assets
Fixed Assets 700.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.92% vs 2.38% in Mar 2024

Annual - Investments
Investments 0.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -58.82% vs 0.00% in Mar 2024

Annual - Current Assets
Current Assets 879.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.66% vs 12.14% in Mar 2024